SIRT7 and melanoma: More intriguingly, SIRT7 has been documented to antagonize TGF-β signaling via direct deacetylation and degradation of SMAD4.42 In melanoma cell, co-immunoprecipitation (co-IP) assay confirmed the direct interaction between SIRT7 and SMAD4 (Fig. 4c).